OR WAIT 15 SECS
© 2020 MJH Life Sciences and Rheumatology Network. All rights reserved.
© 2020 MJH Life Sciences™ and Rheumatology Network. All rights reserved.
October 18, 2016
The 2015 recommendations for PsA treatment highlight the importance of managing comorbidities and a patient-centered treatment approach.
October 07, 2016
When a patient presents with a history of Lyme disease and joint pain, refractory Lyme arthritis seems reasonable, but then, this study warns of systemic arthritis after a Lyme disease infection.
When methotrexate fails in rheumatoid arthritis, the next-line treatment is usually a TNF-α inhibitor. But if this treatment fails as well, what's next?
Identifying the difference between Lyme arthritis or another inflammatory arthritis can be tricky. Here are key signs that your patient may have a systemic inflammatory arthritis rather than Lyme arthritis.